covid-19-disease

Documents about covid-19-disease

• Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)#900272ClinicalTrials.gov
• Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"#918994ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.#995031ClinicalTrials.gov
• Disability inclusion in African health systems’ responses during COVID-19 : a scoping review#228766SUNScholar
• Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients#967034ClinicalTrials.gov
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China#6835OpenAlex
• ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19#849874ClinicalTrials.gov
• Telerehabilitation in Women With Rheumatic Disease#916621ClinicalTrials.gov
• Who writes the pandemic? State power, individual subjectivity, and the history of the present in China's COVID-19 response.#143526PubMed
• A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.#158054ClinicalTrials.gov
• Fourth meeting of the Technical Advisory Group on Safe Schooling during the COVID-19 Pandemic: Copenhagen, Denmark, 9 March 2021#163837WHO IRIS
• Functional Decline in COVID-19 Older Survivors Compared to Other Pneumonia Patients, a Case Control Study#262145HAL (France)
• Cybersecurity Vulnerability Behavior Scale in College During the Covid-19 Pandemic#672009OpenAlex
• Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy#892362ClinicalTrials.gov
• Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study#907785ClinicalTrials.gov
• Trend in Physical Activity Counseling and Cardiometabolic Diseases in Maule, Chile: COVID-19 Pre-Pandemic Study between 2012 and 2019#947582Repositorio de Universidad Autónoma de Chile.
• Health Care Cybersecurity Challenges and Solutions Under the Climate of COVID-19: Scoping Review#976530OpenAlex
• Sociedad e innovación en tiempos de pandemia: el virus que activó la innovación#991163Biblioteca Digital Minerva
• The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine#994932ClinicalTrials.gov
• Changing COVID-19 vaccine eligibility could reshape disease burden for all#234341bioRxiv / medRxiv
• Tele-Physiotherapy After COVID-19 Hospitalization#837552ClinicalTrials.gov
• Antithrombin III in Infectious Disease Caused by COVID-19#910339ClinicalTrials.gov
• COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program#862594ClinicalTrials.gov
• Intubation in Coronavirus Disease 19 With Level 3 PPE#1007797ClinicalTrials.gov
• A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa : 6-month follow-up of hospitalized and nonhospitalized participants#278018SUNScholar
• Privacy in emergency circumstances: data protection and the COVID-19 pandemic#679021OpenAlex
• COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings#679448OpenAlex
• Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis#907461ClinicalTrials.gov
• Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement#881390ClinicalTrials.gov
• Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19#805730ClinicalTrials.gov
• Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine#837304ClinicalTrials.gov
• COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios#95304PhilArchive
• Seirs Covid-19 Pandemic Model with Saturated Incidence Rate Considering Disease Induced Death and Vaccine#112155PhilArchive
• Plasma Rich Antibodies From Recovered Patients From COVID19#912028ClinicalTrials.gov
• Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19)#1017246RI UFLA
• An interactive web-based dashboard to track COVID-19 in real time#6906OpenAlex
• The socio-economic implications of the coronavirus pandemic (COVID-19): A review#7289OpenAlex
• Cybersecurity Concerns & Teleworking in the COVID-19 Era: A Socio-Cybersecurity Analysis of Organizational Behavior#199375OpenAlex
• The Challenges and Opportunities in the Digitalization of Companies in a Post-COVID-19 World#199468OpenAlex
• COVID-19 Disease, Women's Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay#250596IRIS
• Orientations évolutives concernant la prise en charge clinique de la COVID-19 : orientations évolutives, 23 novembre 2021#423687WHO IRIS
• Rethinking digital identity for post-COVID-19 societies: Data privacy and human rights considerations#679037OpenAlex
• Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial#882915ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19#968375ClinicalTrials.gov
• Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness#881601ClinicalTrials.gov
• COVID-19 and its effects on the food production industry of South Africa#385883University of Pretoria Repository
• Post-COVID-19 Outpatient Care and Biomarkers#969636ClinicalTrials.gov
• A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir#860559ClinicalTrials.gov
• The rise and regulation of thermal facial recognition technology during the COVID-19 pandemic#416094OpenAlex
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine#6850OpenAlex